Acquired peripheral neuropathy

Physical Medicine and Rehabilitation Clinics of North America

Volumn 14, Issue 2, 2003, Pages 365-386

  Craig, Anita S W ^a   Richardson, James K ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEMYELINATION; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; ELECTRODIAGNOSIS; HUMAN; MOTOR DYSFUNCTION; NERVE CONDUCTION; NERVE FIBER; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SENSORY DYSFUNCTION; TIME;

EID: 0038689281     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-9651(02)00118-3     Document Type: Review

References (85)

1. Kothari MJ, Blakeslee MA, Reichwein R, Simmons Z, Logigian EL. Electrodiagnostic studies: are they useful in clinical practice. Arch Phys Med Rehabil 1999;79:1510-1.
2. Rapoport AM, Guss SB. Dapsone induced peripheral neuropathy. Arch Neurol 1972; 27:184-5.
3. Franklin GM, Kahn LB, Baxter J, et al. Sensory neuropathy in non-insulin-dependent diabetes mellitus: the San Juis Valley Diabetes Study. Am J Epidemiol 1990;131:633-43.
4. Boyko EJ, Ahroni JG, Stensel V, et al. A prospective study of risk factors for diabetic foot ulcer. Diabetes Care 1999;22(7):1036-42.
5. Reeves ML, Seigler DE, Ayyar DR, et al. Medial plantar sensory response: sensitive indicator of peripheral nerve dysfunction in patients with diabetes mellitus. Am J Med 1984;76(5):842-6.
6. Cavanagh PR, Derr JA, Ulbrecht JS, et al. Problems with gait and posture in neuropathic patients with insulin-dependent diabetes mellitus. Diabet Med 1992;9:469-74.
7. Richardson JK. The clinical identification of peripheral neuropathy among older persons. Arch Phys Med Rehabil, in press.
8. Chalk CH, Dyck PJ, Conn DL. Vasculitic neuropathy. In: Dyck PJ, Thomas PK, Griffin JW, et al, editors. Peripheral neuropathy. 3rd edition. Philadelphia: WB Saunders; 1993. p. 1424-36.
9. Reiber GE, Pecoraro RE, Koepsel TD. Risk factor for amputation in patients with diabetes mellitus: a case control study. Ann Intern Med 1992; 117(2):97-105.
10. McComas AJ, Miller RG, Gandevia SC. Fatigue brought on by malfunction of the central and peripheral nervous systems. Adv Exp Med Biol 1995;384:495-512.
11. Hurvitz EA, Richardson JK, Werner RA. Unipedal stance testing in the assessment of peripheral neuropathy. Arch Phys Med Rehabil 2001;82(2):199-204.
12. Thomas PK, Hillinrake K, Lascelles RG, et al. The polyneuropathy of chronic renal failure. Brain 1971;94:761-80.
13. Abraham RM, Abraham RR. Absence of the sensory action potential of the medial plantar nerve: a sensitive indicator of diabetic neuropathy. Diabet Med 1987;4(5):469-74.
14. Dumitru D, Amato AA, Zwarts MJ. Nerve conduction studies. In: Dumitru D, Amato AA, Zwarts MJ, editors. Electrodiagnostic medicine. 2nd edition. Philadelphia: Hanley & Belfus; 2002. p. 159-223.
15. Cornblath DR, Mellits ED, Griffin JW, et al. Motor conduction studies in Guillain-Barre syndrome: description and prognostic value. Ann Neurol 1988;23:354-9.
16. Combarros O, Calleja J, Figols J, Cabello A, Berciano J. Dominantly inherited motor and sensory neuropathy type I: genetic, clinical, electrophysiological and pathological features in four families. J Neurol Sci 1983;61:181-91.
17. Dyck PB, Windebank AJ. Diabetic and nondiabetic lumbosacral radiculoplexy neuropathies: new insights into pathophysiology and treatment. Muscle Nerve 2002;25: 477-91.
18. Ad Hoc Subcommittee. Research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617.
19. Albers JW, Donofrio PD, McGonagle TK. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1978;1:292-6.
20. Albers JW, Kelly JJ. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 1989;12:435-51.
21. Dumitru D. Generalized peripheral neuropathies. In: Electrodiagnostic medicine. Philadelphia: Hanley & Belfus; 1995. p. 741-833.
22. Cornblath DR. Electrophysiology in Guillain-Barre syndrome. Ann Neurol 1990; 27(Suppl):S17-20.
23. Miller RG, Peterson GW, Daube JR, Albers JW. Prognostic value of electrodiagnosis in Guillian-Barre syndrome. Muscle Nerve 1988;11:769-74.
24. Sander HW, Chokroverty S. Diabetic amyotrophy: current concepts. Semin Neurol 1996; 16(2):173-8.
25. Shields RW. Alcoholic polyneuropathy. Muscle Nerve 1985;8:183-7.
26. Parry GJ. Mononeuropathy multiplex (AAEE case report no. 11). Muscle Nerve 1985;8: 493-8.
27. Mawdsley C, Mayer RF. Nerve conduction in alcoholic polyneuropathy. Brain 1985;88: 335-56.
28. Schaumberg H, Kaplan J, Windeband A, et al. Sensory neuropathy from pyridoxine abuse. N Engl J Med 1983;309:445-8.
29. Shankar K, Maloney FP, Thompson C. An electrodiagnostic study in chronic alcoholic subjects. Arch Phys Med Rehabil 1987;68:803-5.
30. Pourmand R. Diabetic neuropathy. Neurol Clin 1997;15(3):569-76.
31. Stewart JD. Mononeuropathy multiplex. In: Focal peripheral neuropathies. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 509-22.
32. Onet JC. Electrodiagnostic study of a patient with peripheral neuropathy after nitrofurantoin therapy. Arch Phys Med Rehabil 1967;48:209-12.
33. Windebank AJ. Metal neuropathy. In: Dyck PJ, Thomas PK, Griffin JW, et al, editors. Peripheral neuropathy. 3rd edition. Philadelphia: WB Saunders; 1993. p. 1549-70.
34. Kuncl RW, Duncan G, Watson D, et al. Colchicine myopathy and neuropathy. N Engl J Med 1987;316:1562-8.
35. Richardson JK, Ching C, Hurvitz EA. The relationship between electromyographically documented peripheral neuropathy and falls. J Am Geriatr Soc 1992;40(110):1008-12.
36. Pal PK. Clinical and electrophysiological studies in vincristine induced neuropathy. Electromyogr Clin Neurophysiol 1999;39(6):323-30.
37. Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984;47:1223-31.
38. Bolton CF. Electrophysiologic changes in uremic neuropathy after successful renal transplantation. Neurology 1976;26:152-61.
39. Bolton CF. Electrophysiologic studies of critically ill patients. Muscle Nerve 1987;10: 129-35.
40. Waldinger TP, Siegle RJ, Weber W, et al. Dapsone induced peripheral neuropathy. Arch Dermatol 1984;120:356-9.
41. Battaglia M, Mitsumoto H, Wilbourn AJ, et al. Utility of electromyography in the diagnosis of vasculitic neuropathy. Neurology 1990;40(Suppl):427.
42. Kissel JT, Mendell JR. Vasculitic neuropathy. Neurol Clin 1992;10:761-81.
43. Olney RK. Neuropathies in connective tissue disease. Muscle Nerve 1992;15:531-42.
44. Parry GJ, Bredesen DE. Sensory neuropathy with low-dose pyridoxine. Neurology 1985; 35:1466-8.
45. Williams AC, Struman S, Kelesy S, et al. The neuropathy of the critically ill. BMJ 1986; 293:790-1.
46. Ahrens EM, Meckler RJ, Callen JP. Dapsone induced peripheral neuropathy. Int J Dermatol 1986;25:314-6.
47. Navarro JC, Rosales RL, Ordinario AT, et al. Acute dapsone induced peripheral neuropathy. Muscle Nerve 1989;12:604-6.
48. Ramirez JA, Mendell JR, Warmolts JR, et al. Phenytoin neuropathy: structural changes in the sural nerve. Ann Neurol 1986;19:162-7.
49. Vellas BJ, Wayne SJ, Garry PJ, et al. A two-year longitudinal study of falls in 482 community-dwelling elderly adults. J Gerontol Med Sci 1998;53:264-74.
50. Brown WF, Feasby TE, Hahn AF. Electrophysiological changes in the acute "axonal" form of Guillain-Barre syndrome. Muscle Nerve 1993;16:200-5.
51. Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barre polyneuropathy. Brain 1986;109:1115-26.
52. Albers JW, Robertson WC, Daube JR. Electrodiagnostic findings in acute porphyric neuropathy. Muscle Nerve 1978;1:292-6.
53. Flugel KA, Druschky K-F. Electromyogram and nerve conduction in patients with acute intermittent porphyria. J Neurol 1977;214:267-79.
54. Chokroverty S, Sander HW. AAEM case report no. 13: diabetic amyotrophy. Muscle Nerve 1996;19:939-45.
55. Dyck PJ, Lambert EH, Mulder DW. Charcot-Marie-Toothe disease: nerve conduction and clinical studies of a large kinship. Neurology 1963;13:1-11.
56. Ross MA. Neuropathies associated with diabetes. Med Clin North Am 1993;77: 111-24.
57. Mcleod JG. Paraneoplastic neuropathies. In: Dyck PJ, Thomas PK, Griffin JW, et al, editors. Peripheral neuropathy. 3rd edition. Philadelphia: WB Saunders; 1993. p. 1583-90.
58. Donofrio PD, Alessi AG, Albers JW, et al. Electrodiagnostic evolution of carcinomatous sensory neuronopathy. Muscle Nerve 1989;12(6):508-13.
59. Graus F, Elkon KB, Cordon Cardo C, et al. Sensory neuronopathy and small cell lung cancer. Am J Med 1986;80:45-52.
60. Albin RL, Albers JW, Greenberg HS, et al. Acute sensory neuropathy-neuronopathy from pyridoxine overdose. Neurology 1987;37:1729-32.
61. Parry GJ, Sumner AJ. Multifocal motor neuropathy. Neurol Clin 1992;10:671-84.
62. Satya-Murti S, Howard L, Krohel G, et al. The spectrum of neurologic disorder from vitamin E deficiency. Neurology 1986;36:917-21.
63. De Pablos C, Calleja J, Fernandez F, et al. Miller Fisher syndrome: an electrophysiologic study. Electromyogr Clin Neurophysiol 1988;28:21-5.
64. Fross RD, Daube JR. Neuropathy in the Miller Fisher syndrome: clinical and electrophysiologic findings. Neurology 1987;37:1493-8.
65. Chalk CH. Acquired peripheral neuropathy. Neurol Clin 1997;15(3):501-28.
66. Mellgren S, Conn DL, Steven JC, et al. Peripheral neuropathy in primary Sjogren syndrome. Neurology 1989;39:390-4.
67. Laloux P, Brucher JM, Guerit JM, et al. Subacute sensory neuronopathy associated with Sjogren's sicca syndrome. J Neurol 1988;235:352-4.
68. Malinow K, Yannakakis GD, Glusman SM, et al. Subacute sensory neuronopathy secondary to dorsal root ganglionitis in primary Sjogren's syndrome. Ann Neurol 1986; 20:535-7.
69. Riggs JE, Schochet SS, Gutman L, et al. Chronic human colchicine neuropathy and myopathy. Arch Neurol 1986;43:521-3.
70. Bird SJ, Brown MJ. The clinical spectrum of diabetic neuropathy. Semin Neurol 1996; 16(2):115-20.
71. Izzo KL, Sobel E, Demopoulos JT. Diabetic neuropathy: electrophysiologic abnormalities of distal lower extremity sensory nerves. Arch Phys Med Rehabil 1986;67:7-11.
72. Perkins BA, Ngo M, Bril V. Symmetry of nerve conduction studies in different stages of diabetic polyneuropathy. Muscle Nerve 2002;25(2):212-7.
73. Bril V, Nyunt M, Ngo M. Limits of the sympathetic skin response in patients with diabetic polyneuropathy. Muscle Nerve 2000;23(9):1427-30.
74. Bolton CF, Laverty DA, Brown JD, et al. Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 1984;49:563-73.
75. Bolton CJ. Peripheral neuropathies associated with chronic renal failure. Can J Neurol Sci 1980;7:89-96.
76. Bolton CF, Baltzan MA, Baltzan RF. Effects of renal transplantation on uremic neuropathy: a clinical and electrophysiologic study. N Engl J Med 1971;284:1170-5.
77. Oh SJ, Clements RS, Lee YW, et al. Rapid improvement in nerve conduction velocity following renal transplantation. Ann Neurol 1978;4:369-73.
78. Nielsen VK. The peripheral nerve function in chronic renal failure. X. Decremental nerve conduction in uremia. Acta Med Scand 1974;196:83-6.
79. Nielsen VK. The peripheral nerve function in chronic renal failure. V. Sensory and motor conduction velocity. Acta Med Scand 1973;194:445-54.
80. Swift TR, Gross JA, Ward C, et al. Peripheral neuropathy in epileptic patients. Neurology 1991;31:826-31.
81. Bolton CF, Lindsay RM, Linton AL. The course of uremic neuropathy during chronic hemodialysis. Can J Neurol Sci 1975;2:3322-33.
82. Harding AE, Muller DPR, Thomas PK, et al. Spinocerebellar degeneration secondary to chronic intestinal malabsorption: a vitamin E deficiency syndrome. Ann Neurol 1982; 12:419-24.
83. Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333(2):89-94.
84. Saperstein DS, Katz JS, Amato AA, et al. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001;24:311-24.
85. Yiannikas C, Pollard JD, McLeod JG. Nitrofurantoin neuropathy. Aust N Z J Med 1981; 11:400-5.